This Week In Huntington's Disease Research keeps you up-to-date on HDSA research activities, recently published work about Huntington’s disease, historical moments in HD research and more.

Happy Holidays from the HDSA Family 

Posted on December 24, 2020

Despite the challenges of 2020, your support of HDSA this year has continued to remind all of us that in the fight against Huntington’s…

Read More

Publication from an HDSA Fellow 

Posted on December 17, 2020

Congratulations to 2019 Berman-Topper Fellow Dr. Lauren Byrne, whose work was recently published in the Journal Science Translational Medicine. She tweeted this week about…

Read More

The Marker: HDSA’s Annual Research Report

Posted on December 10, 2020

Each year HDSA’s annual research report, The Marker, covers the past year in HD science and HDSA research activities. Check…

Read More

HDSA Announces Four 2020 Human Biology Fellows

Posted on December 3, 2020

This week, HDSA announced the winners of the 2020 HD Human Biology Fellowship. HDSA’s largest research initiative, the Human Biology Project supports projects that focus…

Read More

Happy Thanksgiving

Posted on November 26, 2020

Happy Thanksgiving and a big thank you to members of the HD community for your participation in research. Medicine moves…

Read More

PTC Therapeutics Initiates Phase 1 Clinical Trial

Posted on November 19, 2020

PTC Therapeutics is a company focused on developing genetic and small molecule therapies for rare and serious disorders. This week they issued…

Read More

Triplet Therapeutics SHIELD-HD study fully recruited 

Posted on November 12, 2020

Triplet Therapeutics is a Boston-based biotech company that is developing therapies for CAG repeat disorders like HD. Their focus is studying…

Read More

HDBuzz: Clinical Research Updates from the HSG Conference

Posted on November 5, 2020

The Huntington Study Group hosted a virtual conference from October 29th – 31st, covering clinical trial updates, education, and training for HD…

Read More

HSG 2020: HD in Focus

Posted on October 29, 2020

The Huntington Study Group is a clinical research network focused exclusively on Huntington disease. Each year they host a conference that provides education…

Read More

Novartis Receives FDA Orphan Drug Designation to Study Potential HD Treatment

Posted on October 22, 2020

This week the pharmaceutical company Novartis announced that they had received special status from the FDA, known as Orphan Drug Designation,…

Read More

uniQure Trial Proceeds; Voyager Receives Regulatory Feedback

Posted on October 15, 2020

This week uniQure shared a press release stating that another two patients have entered their HD clinical trial. The drug, AMT-130, is an experimental gene therapy that…

Read More

HDBuzz Covers Virtual EHDN Conference

Posted on October 8, 2020

The European Huntington’s Disease Network hosts a yearly Plenary meeting to discuss the latest in HD science and clinical trials,…

Read More

HD Trialfinder: Study Updates

Posted on October 1, 2020

HDSA’s HD Trialfinder is an easy-to-use website that lists currently recruiting HD clinical trials in the United States and Canada. By answering some basic questions about…

Read More

SIGNAL study of pepinemab does not meet key goals for HD patients  

Posted on September 24, 2020

The SIGNAL study was carried out by a company called Vaccinex to test whether their drug, pepinemab, could combat brain inflammation and ease symptoms…

Read More

Highlights from the EHDN Virtual Congress

Posted on September 17, 2020

This week the 2020 European Huntington’s Disease Network (EHDN) hosted a virtual plenary meeting to discuss the latest in HD research…

Read More

You Asked the Scientists!

Posted on September 10, 2020

The recording from the latest HDSA Research Webinar, Ask the Scientist Anything, is now available on HDSA’s YouTube channel. Dr….

Read More

Research Webinar: Ask the Scientist…Anything! 

Posted on September 3, 2020

This coming Tuesday, September 8th, at 12 PM Eastern, Dr. Ed Wild and Dr. Jeff Carroll, creators of HDBuzz, as well as HDBuzz writers Dr….

Read More

HDBuzz on Somatic Instability

Posted on August 27, 2020

The cause of Huntington’s disease is an extra-long stretch of CAG repeats in the DNA, in a single gene called huntingtin. In…

Read More

Research Spotlight: Telemedicine for Huntington’s Disease

Posted on August 20, 2020

Participants diagnosed with HD, ages 18-70, in the Chicago area, are needed for an HDSA-funded study on Telemedicine at Northwestern…

Read More

HDBuzz: CRISPR Requires Caution

Posted on August 13, 2020

CRISPR is a gene editing technique that has been touted for its potential to treat HD someday in the future. However,…

Read More